In conclusion, our cohort found no association between PD-L1 immunoreactivity and prognosis in CS, LS or UPS, with PD-L1 immunoreactivity being rare in CS and LS but more common in UPS. The gene discussed is CD274; the disease is undifferentiated pleomorphic sarcoma.